DoseMe

Take a look at DoseMe's week at the 21st International Congress of Therapeutic Drug Monitoring and Clinical Toxicology in Oslo. .

We heard the lastest innovations in , , , & .

Fantasic presentation by Dr. João Telles on antimicrobial dose optimization in regions with limited resources, highlighting cost savings up to $350,000 associated with use of software.

REGISTER NOW for a free to hear Tony Lai’s first-hand experiences implementing AUC dosing at The Children's Hospital at Westmead & learn his top tips for making your own business case. 🗓 https://lnkd.in/g9ENZ9-u
Plus, you'll have the opportunity to ask the panel questions live about therapeutic drug monitoring (TDM) of , , & more!

A.C.Camargo Cancer Center Harnesses the Power of DoseMe Precision Dosing Platform to Substantially Reduce Toxicity and Kidney Injuries.

"DoseMe is critical to our team's ability to access real-time data and continue to deliver on our promise of customized care for every single patient." - Dr. Joao Telles, A.C. Camargo Infectious Disease Specialist.

At , Dr. Telles shared the results of A.C.Camargo's precision dosing initiative which included a 70% decrease in the rate of AKI.

Full article here: https://doseme-rx.com/news-media/articles/ac-camargo-cancer-center-harnesses-the-power-of-dosemerx

More data to be presented upcoming International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) Congress.
**Dr. Telles Presentation: TDM in Countries with Other Resources, Focus on Costs**

A.C. Camargo Cancer Center Harnesses the Power of DoseMeRx A.C. Camargo Cancer Center achieves 70% decrease in AKI in oncology patients using DoseMeRx for therapeutic drug monitoring

Join us on September 19 at 8pm ET/September 20 at 10am AEST to gain insight into the key benefits of AUC-guided TDM for , , & . Register for the here ➡ https://lnkd.in/g9ENZ9-u

In this free Tony Lai, Senior Pharmacist, Antimicrobial Stewardship/Infectious Diseases, at Children’s Hospital at Westmead, Australia makes the case for AUC-guided therapeutic drug monitoring (TDM) of aminoglycosides.

Sign up to join us live on September 19 at 8pm ET/September 20 at 10am AEST: https://lnkd.in/g9ENZ9-u

Can't make this date? Register now to ensure you'll receive a recording.

Health Tech organizations face tremendous pressure to innovate while fully complying with security protocols. HITRUST r2 Certification validates that DoseMe’s technology platform has met key standards and industry-specific requirements and is effectively approaching risk management.

“There is a significant difference between simply operating on a HITRUST platform or cloud versus having a full certification, validating and confirming the organization is a trustworthy data steward,” said Dr. Joseph Ketcherside, Chief Compliance Officer.

Read the full article here > https://doseme-rx.com/?p=10375&preview=true&_thumbnail_id=8881

DoseMe Achieves HITRUST Certification As the only HITRUST certified precision dosing platform, DoseMe is committed to strong cybersecurity & meeting key regulations to protect sensitive data.

We're thrilled to announce that New England Life Care, a home infusion therapy & specialty pharmacy services provider, selected DoseMeRx for precision dosing of & ! Learn more about our partnership here >> doseme-rx.com/news-media/articles/new-england-life-care-selects-doseme

New England Life Care Selects DoseMe New England Life Care, home infusion & specialty pharmacy provider, selected DoseMe for precision dosing of vancomycin & aminoglycosides

"Revolutionize" dosing at your hospital with DoseMeRx! Check out the full list of clinicially validated pharmacokinetic models for , , & more >> https://lnkd.in/gYASD3SY

The energy at DoseMe just grew threefold! Our company's executive leadership team expanded with appointments of Paul Edwards to CEO, John Hardesky to CCO & Sharmeen Roy to Chief Strategy & Science Officer. Read full release here: https://doseme-rx.com/news-media/articles/doseme-expands-leadership-team

Stay tuned for more exciting news around our customers, partners, & the precision dosing industry at large.

DoseMe Expands Leadership Team DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to CSSO

Red man syndrome, also known as vancomycin flushing syndrome, is an adverse reaction characterized by flushing & erythema that can occur after the administration of certain medications, particularly . Read our latest article to learn how to recognize & manage this condition to improve patient outcomes. 👉

Red Man Syndrome: A Close Look at Causes, Symptoms, and Treatment • DoseMeRx Red man syndrome is a reaction related to the infusion of vancomycin. Take a closer look at this condition & how to manage it here.

✨ New on-demand webinar: ✨ A panel of clincial experts share their data-driven approach to therapeutic drug monitoring, leveraging EHR integrated software & real-time data in DoseMeRx. Watch here ▶ https://doseme-rx.com/webinars/recorded-webinar/mastering-big-data-tdm

🙌